Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma
Asim Amin, David H. Lawson, April K.S. Salama, Henry B. Koon, Troy Guthrie, Sajeve S. Thomas, Steven J. O'Day, Montaser F. Shaheen, Bin Zhang, Stephen Francis, F. Stephen Hodi
Producción científica: Article › revisión exhaustiva
Profundice en los temas de investigación de 'Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma'. En conjunto forman una huella única.